Diakine-DK2 10 (EGFR)

N/A

Report date: 2025/07/29 20:00:11

Base Information

Drug NameDiakine-DK2 10 (EGFR)
Drug Alias NameDK210DK-2-10
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor agonistsInterleukin 10 receptor stimulantsAnti-Epidermal growth factor receptor erbB1
TargetsEpidermal growth factor receptor erbB1Interleukin-2 receptorInterleukin 10 receptor
Therapy Area/IndicationsSolid tumoursKidney NeoplasmsGenital Neoplasms, Female +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDeka Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesDeka Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursKidney NeoplasmsGenital Neoplasms, Female +[8] 
Inactive IndicationsCarcinoma, Renal CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A